Correlation Between Dupont De and BridgeBio Pharma
Can any of the company-specific risk be diversified away by investing in both Dupont De and BridgeBio Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dupont De and BridgeBio Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dupont De Nemours and BridgeBio Pharma, you can compare the effects of market volatilities on Dupont De and BridgeBio Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dupont De with a short position of BridgeBio Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dupont De and BridgeBio Pharma.
Diversification Opportunities for Dupont De and BridgeBio Pharma
-0.33 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Dupont and BridgeBio is -0.33. Overlapping area represents the amount of risk that can be diversified away by holding Dupont De Nemours and BridgeBio Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BridgeBio Pharma and Dupont De is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dupont De Nemours are associated (or correlated) with BridgeBio Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BridgeBio Pharma has no effect on the direction of Dupont De i.e., Dupont De and BridgeBio Pharma go up and down completely randomly.
Pair Corralation between Dupont De and BridgeBio Pharma
Allowing for the 90-day total investment horizon Dupont De Nemours is expected to generate 0.48 times more return on investment than BridgeBio Pharma. However, Dupont De Nemours is 2.07 times less risky than BridgeBio Pharma. It trades about 0.01 of its potential returns per unit of risk. BridgeBio Pharma is currently generating about -0.01 per unit of risk. If you would invest 8,330 in Dupont De Nemours on August 26, 2024 and sell it today you would earn a total of 2.00 from holding Dupont De Nemours or generate 0.02% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Dupont De Nemours vs. BridgeBio Pharma
Performance |
| Timeline |
| Dupont De Nemours |
| BridgeBio Pharma |
Dupont De and BridgeBio Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Dupont De and BridgeBio Pharma
The main advantage of trading using opposite Dupont De and BridgeBio Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dupont De position performs unexpectedly, BridgeBio Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BridgeBio Pharma will offset losses from the drop in BridgeBio Pharma's long position.| Dupont De vs. Olin Corporation | Dupont De vs. Cabot | Dupont De vs. Kronos Worldwide | Dupont De vs. LyondellBasell Industries NV |
| BridgeBio Pharma vs. Blueprint Medicines Corp | BridgeBio Pharma vs. Amylyx Pharmaceuticals | BridgeBio Pharma vs. Day One Biopharmaceuticals | BridgeBio Pharma vs. Terns Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |